Hussman Strategic Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,400
Closed -$1M 315
2023
Q1
$1M Sell
12,400
-8,400
-40% -$676K 0.16% 215
2022
Q4
$1.56M Sell
20,800
-25,700
-55% -$1.83M 0.25% 159
2022
Q3
$3M Hold
46,500
0.52% 58
2022
Q2
$3.22M Buy
46,500
+36,100
+347% +$2.68M 0.56% 47
2022
Q1
$799K Hold
10,400
0.16% 204
2021
Q4
$796K Sell
10,400
-8,200
-44% -$603K 0.17% 187
2021
Q3
$1.37M Sell
18,600
-12,400
-40% -$930K 0.3% 131
2021
Q2
$2.07M Buy
+31,000
New +$2.07M 0.43% 81
2017
Q4
Sell
-50,000
Closed -$1.83M 199
2017
Q3
$1.83M Buy
+50,000
New +$2.02M 0.44% 99

Other funds holding HOLX

Hussman Strategic Advisors's HOLX Position: Q2 2023 in Review

Hussman Strategic Advisors sold out of Hologic (HOLX) in Q2 2023, closing a stake of 12,400 shares — an estimated $1M sold.

Hussman Strategic Advisors first reported a position in HOLX in Q3 2017 and held it in 9 quarters. The position peaked at $3.22M in Q2 2022. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Hussman Strategic Advisors reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 12,400 Hologic shares in Q2 2023, an estimated $1M.
  • Hussman Strategic Advisors first reported a position in Hologic in Q3 2017 and held it in 9 quarters.
  • Hussman Strategic Advisors's Hologic position peaked at $3.22M in Q2 2022.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Hussman Strategic Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.